Vitamin A-like Drug Cuts The Risk Of Second Breast Cancers In Young Women
Description
15-year follow-up of women in a breast cancer trial has found that fenretinide[1] --- a drug related to vitamin A --- significantly cuts the risk of a second breast cancer among younger patients.